Agilemed Investments Private Limited has disclosed the creation of a pledge on 62,51,066 equity shares of MedPlus Health Services Limited, representing 5.20% of the company’s total voting capital. This disclosure, made on August 21, 2026, pertains to the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The pledge is in favour of Catalyst Trusteeship Limited, acting as Debenture Trustee for debenture holders.
Equity Pledge Disclosure
Agilemed Investments Private Limited has officially disclosed a pledge affecting 62,51,066 equity shares in MedPlus Health Services Limited. This transaction represents 5.20% of the total voting capital of MedPlus Health Services Limited. The disclosure was made in accordance with Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Pledge Details
The pledge was created in favour of Catalyst Trusteeship Limited, which is acting in its capacity as a Debenture Trustee. This arrangement serves to benefit the debenture holders. The creation of the pledge is categorized under ‘Shares in nature of encumbrance’ for reporting purposes.
Transaction Context
The disclosure indicates that prior to this transaction, Agilemed Investments Private Limited held no shares in the nature of encumbrance. Post the creation of this pledge, the total holding in the nature of encumbrance for Agilemed Investments amounts to 62,51,066 shares, maintaining the 5.20% stake. The total diluted share capital of MedPlus Health Services Limited after this transaction remains at 12,02,37,751.
Specific Encumbrance Details
The pledged equity shares are broken down into three encumbrances:
- Encumbrance I: A pledge of 4,851,066 equity shares created on December 16, 2025.
- Encumbrance II: A pledge of 900,000 equity shares created on July 24, 2026.
- Encumbrance III: A pledge of 500,000 equity shares created on August 19, 2026.
The disclosure was authorized by Deesha Srikkanth, Senior Vice President at Catalyst Trusteeship Limited, on August 21, 2026.
Source: BSE
